Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Relay Therapeutics Inc (NQ: RLAY ) 6.440 -0.120 (-1.83%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 14, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Relay Therapeutics Inc < Previous 1 2 3 4 5 6 7 Next > 3 Precision Medicine Stocks That Could Benefit From the Industry’s Rise March 15, 2024 Dive into the potential of precision medicine stocks poised to revolutionize healthcare and offer substantial growth opportunities. Via InvestorPlace AI-Powered Drug Discovery Stocks Index Up 9% In February; Remains Down 8% YTD March 04, 2024 Grand View Research says the global Via Talk Markets Relay Therapeutics to Participate in Three Upcoming Investor Conferences February 26, 2024 From Relay Therapeutics, Inc. Via GlobeNewswire Relay Therapeutics: Q4 Earnings Insights February 22, 2024 Via Benzinga Relay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights February 22, 2024 From Relay Therapeutics, Inc. Via GlobeNewswire Relay Therapeutics's Earnings: A Preview February 21, 2024 Via Benzinga Relay Therapeutics's Earnings Outlook November 01, 2023 Via Benzinga Earnings Scheduled For February 22, 2024 February 22, 2024 Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on revenue of $260.00 million. Via Benzinga AI-Powered Drug Discovery Stocks Index Up 18% Last Week, Led By BioXcel Therapeutics February 19, 2024 The AI-powered drug discovery market is projected to grow at a 30% CAGR between now and 2030, with annual sales in excess of $50 billion anticipated. An AI drug discovery revolution is underway. Via Talk Markets Topics Artificial Intelligence Exposures Artificial Intelligence Relay Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights on February 22, 2024 February 15, 2024 From Relay Therapeutics, Inc. Via GlobeNewswire The 7 Best Penny Stocks for 200% Returns February 06, 2024 Penny stocks often possess significant upside and these are no different with 200% returns expected by analysts. Via InvestorPlace Relay Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference February 01, 2024 From Relay Therapeutics, Inc. Via GlobeNewswire Relay Therapeutics Announces $30 Million Private Placement Financing January 08, 2024 From Relay Therapeutics, Inc. Via GlobeNewswire Relay Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference January 02, 2024 From Relay Therapeutics, Inc. Via GlobeNewswire AI-Focused Drug Discovery Stocks Index Up 26% In December December 29, 2023 With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds massive potential to increase the accessibility of drugs and to treat presently incurable conditions. Via Talk Markets AI-Focused Drug Discovery Stocks Index Up 10.6% Last Week December 17, 2023 A new study concludes that the AI method of drug discovery is up to 250 times more efficient than the traditional method. Via Talk Markets Topics Artificial Intelligence Exposures Artificial Intelligence 12 Health Care Stocks Moving In Wednesday's Pre-Market Session December 13, 2023 Via Benzinga HC Wainwright & Co. Maintains Buy Rating for Relay Therapeutics: Here's What You Need To Know December 11, 2023 Via Benzinga The 10 Stocks Using AI To Develop New Drugs Were Up 4%, On Average, Last Week December 11, 2023 If, as Morgan Stanley postulates, a $50 billion AI drug discovery revolution is underway, here are 10 publicly-traded micro- and small-cap clinical stage pharma companies that are embracing AI to... Via Talk Markets Topics Artificial Intelligence Exposures Artificial Intelligence Micro/Small Cap Companies Using AI In Drug Discovery Up 35% In November December 06, 2023 The AI method is up to 250 times more efficient than the traditional method of drug discovery. reducing timelines for drug discovery, increasing accuracy of efficacy and safety predictions. Via Talk Markets Topics Artificial Intelligence Exposures Artificial Intelligence Unlocking AI investment opportunities in healthcare November 16, 2023 AI is revolutionizing healthcare by improving diagnosis and accelerating drug discovery. An often-overlooked sector with a wealth of AI opportunities. Via MarketBeat Topics Artificial Intelligence ETFs Exposures Artificial Intelligence AI Alert: 3 Healthcare Stocks That Are Investing in Artificial Intelligence November 09, 2023 We’re still in the initial stages of a massively disruptive artificial intelligence (AI) boom that's greatly impacting healthcare. Via InvestorPlace Topics Artificial Intelligence Exposures Artificial Intelligence Relay Therapeutics to Participate in Stifel 2023 Healthcare Conference November 07, 2023 From Relay Therapeutics, Inc. Via GlobeNewswire Relay Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Highlights November 02, 2023 From Relay Therapeutics, Inc. Via GlobeNewswire Earnings Scheduled For November 2, 2023 November 02, 2023 Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million. Via Benzinga Relay Therapeutics to Announce Third Quarter 2023 Financial Results and Corporate Highlights on November 2, 2023 October 26, 2023 From Relay Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's After-Market Session October 12, 2023 Via Benzinga Relay Therapeutics Announces Initial RLY-4008 (lirafugratinib) Data Demonstrating Durable Responses Across Multiple FGFR2-Altered Solid Tumors October 12, 2023 From Relay Therapeutics, Inc. Via GlobeNewswire Stocks That Hit 52-Week Lows On Tuesday September 26, 2023 On Tuesday, 386 stocks made new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Tuesday September 19, 2023 During Tuesday's session, 275 companies made new 52-week lows. Via Benzinga < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.